Price Target Analysis of: Medical Transcription Billing, Corp. (MTBC)

Medical Transcription Billing, Corp. (MTBC) plummeted -12.26 percent and ended the day at $1.36. The Average Volume of the company is 582.72 Million and P/E (price to earnings) ratio is 0, while Forward P/E ratio is 0.

The highest price MTBC stock touched in the last 12 month was $2.18 and the lowest price it hit in the same period was $0.29. The stock has a Return on Assets of -36.4 percent, Return on Investment of -38.4 percent and a Return on Equity of -90.3 percent. The company’s market cap is $15.59 Million.

A price target is the projected price level of a financial security stated by an investment analyst. It represents a security’s price that, if achieved, results in a trader recognizing the best possible outcome for his investment. This is the price at which the trader or investor wants to exit his existing position so he can realize the most reward.

Medical Transcription Billing, Corp. (MTBC) has been given an average price target of $1.85 from analysts, according to data collected by Finviz.

Now we look at the Moving Averages, the 200-day is 66.54, the 50-day is 102.15 and the 20-day is 116.97. Moving averages are used as a strong indicator for technical stock analysis and it helps investors in figuring out where the stock has been and also help in determining where it may be possibly heading.

Looking forward, the company is expected to report earnings of $-0.24 per share for the current quarter. Revenue is expected in between 8 Million and 8 Million with an average of 8 Million.

Medical Transcription Billing, Corp. (MTBC) has an Average Brokerage Recommendation (ABR) of 1, according to data compiled by Zacks Investment Research. The recommendation scale measures the value from 1 to 5, where 1 means ‘’Strong Buy’’ and 5 stands for ’’Sell’’.

Medical Transcription Billing, Corp. was covered by a number of analysts recently, 0 rated the stock as Buy, 1 rated Outperform, 0 rated Hold, 0 gave an Underperform and 0 rated sell.

Medical Transcription Billing, Corp. (MTBC) performance during the last one year Improved 36 percent, while its year to date (YTD) performance showed a Positive trend of 87.59 percent. The stock Jumped 63.86 percent over the past six months. The stock’s quarterly performance indicates a Positive momentum of 67.9 percent, whereas its last one month trend is Optimistic with 109.23 percent. Its weekly performance showed an upward trend of 202.22 percent.

Profitability analysis helps a great deal in making investment decision. Net profit margin of the company was recorded at -39 percent, operating profit margin was -32.6 percent, whereas gross profit margin stands at 45.2 percent. Beta factor was calculated at 0.

Medical Transcription Billing, Corp. (MTBC) has 11.46 Million shares outstanding and 4.55 Million shares were floated in market. The short ratio in the company’s stock is documented at 0.01 and the short float is around of 0.09%. The stock’s average true range of stands at 0.27, while the relative strength index is 71.91.

Liquidity ratios helps investors to determine a company’s ability to pay off its debts. For the most recent quarter, quick ratio was 0.5, current ratio was 0.5, LT Debt/Equity ratio was 0.59 and Total Debt/Equity ratio was 1.97.